Minimum age set for puberty blockers trial To participate in the ‘PATHWAYS’ clinical trial, a modified protocol has ruled that birth-registered females must be aged between 11 and 16 years, and birth-registered males must be aged between 12 and 16 years.…
Why a research mindset matters in critical care pharmacy and beyond The Royal College of Pharmacy’s chief scientist reports back on a conversation with Cathrine McKenzie, professor of intensive care pharmacy at the University of Southampton, about the contribution that practising pharmacists can make to research.…
MS drug found to benefit patients with more advanced disease Researchers reported that ocrelizumab significantly reduced the risk of disability worsening in wheelchair-dependent patients.…
Legislation to speed up clinical trials comes into force The law change enables researchers to simultaneously apply for ethics and regulatory approval for new clinical trials of investigational medicinal products.…
Pharmacy research must help shape the profession’s next chapter The Royal College of Pharmacy’s chief scientist shares learnings from the career and research of David Jones, winner of the Hanbury Medal 2025, for outstanding contributions to the pharmaceutical sciences.…
The long road to replacing animals in pharmaceutical research Researchers, regulators and industry are working to develop and implement alternatives to animal testing as part of a new government strategy, but experts warn that it may be impossible to completely phase out animal use entirely.…
Mapping the landscape: an insight into women’s health pharmacy staffing across the UK Women’s health pharmacy is a growing specialty, but there are too few pharmacists in each trust that focus on this area, as members of the UK Clinical Pharmacy Association women’s health committee discovered in a novel benchmarking project.…
Pharmacy research: driving safer outcomes in substance misuse Research offers a crucial opportunity in shaping healthcare policy and practice, particularly in the developing landscape of substance misuse.…
EMA proposes modifying pre-existing clinical trials during public health emergencies Draft guidance has suggested trial adaptations, including changing endpoints, introducing new patient cohorts, adding new trial arms and adapting randomisation.…
Almost £50m from pharmacy manufacturers’ levy to be used for expansion of NHS clinical trials The National Institute for Health and Care Research said the funding will be used to provide equipment to 51 NHS trusts and 79 primary care organisations across England.…
